alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
##### 



Exhibit 21.1
 Subsidiaries of Registrant
 Company Name
    
    JurisdictionDomestic Subsidiaries:Birch Nantucket Holding Company, LLC
    
    DelawareKensington Laboratories, Inc. (inactive)
    
    CaliforniaNewport Domestic International Sales Corporation (inactive)
    
    CaliforniaNewport European Distribution Company
    
    CaliforniaNewport Finance Company I, LLC
    
    DelawareNewport Finance Company II, LLC
    
    DelawareNewport Franklin, Inc. (indirect)
    
    DelawareNewport Government Systems, Inc. (inactive)
    
    CaliforniaNewport Inspection Holdings, Inc. (inactive)
    
    MichiganNewport Precision Optics Corporation
    
    New YorkNewport Rochester, Inc. (indirect)
    
    DelawareSpectra-Physics Optics Corporation (indirect; inactive)
    
    CaliforniaSpectra-Physics Semiconductor Lasers, Inc. (indirect)
    
    DelawareUnique Equipment Co. (inactive)
    
    ArizonaForeign Subsidiaries:Hilger Analytical Limited (indirect; inactive)
    
    United KingdomHilger Crystals Limited (indirect)
    
    United KingdomMicro Controle Finance Holding 1 (indirect)
    
    FranceMicro Controle Finance Holding 2 (indirect)
    
    FranceMicro Controle Holdings Ltd. (inactive)
    
    United KingdomMicro Controle Italia S.r.l.
    
    ItalyMicro Controle Ltd. (indirect; inactive)
    
    United KingdomMicro Controle Spectra-Physics S.A.S.
    
    FranceMicro Controle UK Ltd. (indirect; inactive)
    
    United KingdomMRSI Asia Pte. Ltd.
    
    SingaporeMRSI Europe, B.V.
    
    NetherlandsNewport Corporation (Barbados) SRL
    
    BarbadosNewport Instruments AG (inactive)
    
    SwitzerlandNewport Instruments Canada Corporation
    
    CanadaNewport Spectra-Physics B.V.
    
    NetherlandsNewport Spectra-Physics GmbH (indirect)
    
    GermanyNewport Spectra-Physics Ltd.
    
    United KingdomNewport Opto-Electronics Technologies (indirect; inactive)
    
    ChinaNewport Opto-Electronics Technologies (Wuxi) Company Limited
    
    ChinaSpectra-Physics K.K.
    
    JapanSpectra-Physics Lasers Limited (indirect; inactive)
    
    United KingdomSpectra-Physics Limited (indirect; inactive)
    
    United Kingdom
SNAP STAKEHOLDER MEETING

August 22, 2013

1:30 PM – 4:00 PM EDT

Capital Hilton, 1001 16th Street NW, Washington, DC 20036

EPA is hosting a stakeholder meeting for interested stakeholders to exchange information on 

the Significant New Alternatives Policy (SNAP) program. On June 25, 2013, President Obama 

announced the Climate Action Plan that will “[keep] the United States of America a leader, a global 

leader in the fight against climate change.” As part of his plan, President Obama directed EPA to 

use its authority through the SNAP Program “to encourage private-sector investment in lowemissions technology by identifying and approving climate-friendly chemicals while prohibiting 

certain uses of the most harmful chemical alternatives.” 

The SNAP program was established in 1994 by Section 612 of the Clean Air Act to ensure that 

alternatives to ozone-depleting substances used in key sectors pose lower overall risk to human 

health and the environment than what is currently or potentially available. Toward that end, SNAP 

reviews alternatives based on toxicity, flammability, ozone-depletion potential, global warming 

potential, environmental fate, and other criteria. 

SNAP has listed hundreds of acceptable alternatives, and in this process has valued highly our 

engagement with our stakeholders. The purpose of this meeting is to begin a dialogue between 

stakeholders and EPA on next steps and effective approaches going forward to meet the goals laid 

out in the Climate Action Plan for the SNAP program.

Agenda

1. Welcome & Introductions 

2. Overview: the Climate Action Plan and HFCs

3. The SNAP Program 

a. Discussion

4. Complementary Approaches 

a. Discussion

5. Additional Discussion 

6. Conclusion & Next Steps 
Key Discussion Questions

To help frame our discussion, please consider the following questions ahead of the meeting on 

August 22nd. We look forward to engaging in a discussion on these and other topics you may 

wish to raise.

 What are some ways that SNAP can help “encourage private-sector investment in lowemissions technolog[ies](?)”

 While responding to the Climate Action Plan’s goal of “prohibiting certain uses of the most 

harmful” alternatives, how can SNAP provide a degree of certainty for future investments?

 In what end uses are low-GWP alternatives already being used? 

 What barriers do companies face in developing additional low-GWP alternatives?

 Under what circumstances/conditions would it make sense for EPA to change the listing 

status of certain high-GWP HFCs?

 What transition times would be needed to move to alternatives?

 What end uses will require continued servicing and for how long?

 Are there complementary approaches that can achieve further GHG reductions? 

 What could complementary approaches achieve?
EXHIBIT 32

 

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report of Renovo Holdings (the "Company") on Form 10-QSB for the period ended September 30, 2006, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Stephen W. Carnes, President and Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

 

|   | (1) | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
|--------|-----|-----------------------------------------------------------------------------------------------------------------------|

 

|   | (2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
|--------|-----|------------------------------------------------------------------------------------------------------------------------------------------------------|

 

 

|   | /s/ Stephen Carnes                                    |
|--------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | Stephen W. Carnes |
|--------|-------------------|

|   | Chief Executive Officer and Principal |
|--------|---------------------------------------|

Financial Officer

 

|   | November 14, 2006 |
|--------|-------------------|
EXHIBIT 32.1






CERTIFICATION PURSUANT TO


18 U.S.C. SECTION 1350,


AS ADOPTED PURSUANT TO


SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002






In connection with the Quarterly Report of GlobeTrac Inc. (the “Company”) on Form 10-Q for the period ending March 31, 2010 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, John daCosta, President and Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:




(1)   The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and






(2)   The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.






/s/John daCosta


Chief Executive Officer


May 14, 2010
**EXHIBIT 32.2**

**CERTIFICATION OF**

**CHIEF FINANCIAL OFFICER**

**OF MAX CAPITAL GROUP LTD.**

This certification isprovided pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. § 1350, and accompanies the quarterly report on Form 10-Q (the “Form 10-Q”) for the quarter ended June 30, 2007 of Max Capital Group Ltd. (the“Issuer”). 

I, Joseph W. Roberts, the Chief Financial Officer of Issuer certify that: 

(i) the Form 10-Q fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934 (15 U.S.C.78m(a) or 78o(d)); and 

(ii) the information contained in the Form 10-Q fairly presents, in all material respects, the financial conditionand results of operations of the Issuer. 

A signed original of this written statement required by Section 906, or other document authenticating,acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to the Issuer and will be retained by the Issuer and furnished tothe Securities and Exchange Commission or its staff upon request. 

Dated: July 31, 2007
Exhibit 32.2

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

The undersigned, the Chief Financial Officer of Gladstone Capital Corporation (the Company), hereby certifies on the date hereof, pursuant to 18
U.S.C. §1350(a), as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report on Form 10-Q for the quarter ended June 30, 2018 (Form 10-Q), filed concurrently herewith by the Company, fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934 and that the information contained in
the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated: July 31, 2018



|                                     
|-------------------------------------
|/s/NicoleSchaltenbrand               
|Nicole Schaltenbrand                 
|Chief Financial Officer and Treasurer
Donald 

### Marvin Mayor Sincerely, Thank you for your time and attention to this very important matter at hand. Thank you for allowing me to express my support for this application for certificate of public service. The Alicia Roberts Medical Center located here in Klawock, relies on Harris Air to deliver pharmaceutical supplies from the Hospital in Sitka. Without a regular schedule of flights the residents on Prince of Wales would have a much harder time receiving medications. Their schedule allows for our citizens to plan much needed trips to medica] facilities located in Sitka. As well as our staff s ability to attend 

### training in 

### Sitka in 

### acost 

### effective manner by being able to travel directly from Klawock to Sitka. I am writing this letter 

### in support of Harris Aircraft Services, Inc. application for certificate of public convenience. Harris Air has proven to be a very reliable air carrier for air traffic between Sitka and Klawock. Dear Ms. Remo, Lauralyn (Laura) J. Remo DOT, Office of Aviation Analysis, Air Carrier Fitness Division, 

### X-56 1200 New Jersey Avenue, S.E. Washington D.C. 20590 September 4,2014 "Site of the First Salmon Cannery In Alaskall Phone# (907)755-2261 (907)755-2262 Fad (907)755-2403 PO Box 469 Klawock 

### AI< 99925 

# CITY OF KLAWOCK ALASKA
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         National Institute on Drug Abuse Initial Review Group; Medication Development Research Study Section.                              ( print page 5250)    

*Date:*                         March 13, 2024.                    

*Time:*                         9:00 a.m. to 5:00 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         National Institute of Health, National Institute on Drug Abuse, 301 North Stonestreet Avenue, Bethesda, MD 20892.                    

*Contact Person:*                         Preethy Nayar, Ph.D., Scientific Review Officer, Scientific Review Branch, National Institute on Drug Abuse, NIH, 301 North Stonestreet Avenue, MSC 6021, Bethesda, MD 20892, 301-443-4577,                         *nayarp2@csr.nih.gov*.                    

(Catalogue of Federal Domestic Assistance Program Nos. 93.277, Drug Abuse Scientist Development Award for Clinicians, Scientist Development Awards, and Research Scientist Awards; 93.278, Drug Abuse National Research Service Awards for Research Training; 93.279, Drug Abuse and Addiction Research Programs, National Institutes of Health, HHS)

Dated: January 22, 2024.

Lauren A. Fleck,

Program Analyst, Office of Federal Advisory Committee Policy.

[FR Doc. 2024-01568 Filed 1-25-24; 8:45 am]

BILLING CODE 4140-01-P
II

104TH CONGRESS

2D SESSION S. 1840

To amend the Federal Trade Commission Act to authorize appropriations

for the Federal Trade Commission.

IN THE SENATE OF THE UNITED STATES

JUNE 5, 1996

Mr. PRESSLER (for himself, Mr. GORTON, Mr. HOLLINGS, Mr. BRYAN, and

Ms. SNOWE) introduced the following bill; which was read twice and referred to the Committee on Commerce, Science, and Transportation

A BILL

To amend the Federal Trade Commission Act to authorize

appropriations for the Federal Trade Commission.

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled,

3 SECTION 1. SHORT TITLE.

4 This Act may be cited as the ‘‘Federal Trade Com5 mission Reauthorization Act of 1996’’.

6 SEC. 2. REAUTHORIZATION.

7 Section 25 of the Federal Trade Commission Act (15

8 U.S.C. 57c) is amended by striking ‘‘and not to exceed’’

9 and inserting ‘‘not to exceed’’ and by inserting before the

10 period the following: ‘‘; not to exceed $107,000,000 for
2

•S 1840 IS

1 fiscal year 1997; and not to exceed $111,000,000 for fiscal

2 year 1998’’.

Æ
Exhibit 31.1

                                  CERTIFICATION


I, Michael Chang, CFO, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Myoffiz,
Inc.;

2. Based on my knowledge, this quarterly report does not contain any
untrue statement of a material fact or omit to state a material fact
necessary to make the statements made, in light of the circumstances
under which such statements were made, not misleading with respect to
the period covered by this quarterly report;

3. Based on my knowledge, the financial statements, and other
financial information included in this quarterly report, fairly
present in all material respects the financial condition, results of
operations and cash flows of the registrant as of, and for, the
periods presented in this quarterly report;

4. I am responsible for establishing and maintaining disclosure
controls and procedures (as defined in Exchange Act Rules 13a-15(e)
and 15d-15(e)) for the registrant and we have:

      a) designed such disclosure controls and procedures, or caused
such disclosure controls and procedures to be designed under our
supervision, to ensure that material information relating to the
registrant is made known to us by others within the Corporation,
particularly during the period in which this quarterly report is
being prepared;

      b) evaluated the effectiveness of the registrant's disclosure
controls and procedures and presented in this report our conclusions
about the effectiveness of the disclosure controls and procedures, as
of the end of the period covered by this report based on such
evaluation; and

      c) disclosed in this report any change in the registrant's
internal control over financial reporting that occurred during the
registrant's most recent fiscal quarter that has materially affected,
or is reasonably likely to materially affect, the registrant's
internal control over financial reporting; and

5. I have disclosed, based on my most recent evaluation of internal
control over financial reporting, to the registrant's auditors and
the audit committee of registrant's board of directors (or persons
performing the equivalent function):

      a) all significant deficiencies and material weaknesses in the
design or operation of internal control over financial reporting
which are reasonably likely to adversely affect the registrant's
ability to record, process, summarize and report financial
information; and

      b) any fraud, whether or not material, that involves management
or other employees who have a significant role in the registrant's
internal control over financial reporting.




Date:  JANUARY 14, 2004

                              /s/ MICHAEL CHANG
                              ---------------------------
                              Michael Chang
                              CFO
## Court of Appeals Sixth Appellate District of Texas

J U D G M E N T

Sheila Ardry Jones, Appellant

No. 06

- 19

- 00065

- CR v.

The State of Texas, Appellee Appeal from the 2nd District Court of Cherokee County, Texas (Tr. Ct. No.

20628 ). Memorandum Opinion delivered by Chief Justice Morriss, Justice Burgess and Justice Stevens participating.

As stated in the Court’s opinion of this date, we find there was partial error in the judgment

of the court below. Therefore, we modify the trial court’s judgment by deleting the assessment of

attorney fees and to reflect that Jones was convicted of a third

- degree felony. As modified, the

judgment of the trial court is affirmed.

We note that the appellant, Sheila Ardry Jones, has adequately i ndicated h er inability to

pay costs of appeal. Therefore, we waive payment of costs.

RENDERED NOVEMBER 1, 2019

BY ORDER OF THE COURT JOSH R. MORRISS, III

CHIEF JUSTICE

ATTEST: Debra K. Autrey, Clerk
#### Douglas Lee HUSKETH, Plaintiff-Appellant, v. Theodis BECK; Michael S. Hamden, Defendants-Appellees.

No. 02-7608.

United States Court of Appeals, Fourth Circuit.

Submitted Jan. 16, 2003.

Decided Jan. 24, 2003.

Douglas Lee Husketh, Appellant Pro Se.

Before WILLIAMS, KING, and GREGORY, Circuit Judges.

Affirmed by unpublished PER CURIAM opinion.

PER CURIAM.

Douglas Lee Husketh appeals the district court’s order denying relief on his 42 U.S.C. § 1983 (2000) complaint. We have reviewed the record and find no reversible error. Accordingly, we affirm on the reasoning of the district court. *See Husketh v. Beck,*No. CA-02-583-5 BO (E.D.N.C. Sept. 17, 2002). We deny Husketh’s “motion requesting this court to direct the Department of Corrections to tax Plaintiffs trust fund for cost of suit.” We dispense with oral argument because the facts and legal contentions are adequately *158presented in the materials before the court and argument would not aid the decisional process.

*AFFIRMED.*
**EXHIBIT 32**WRITTEN STATEMENTPURSUANT TO18 U.S.C. SECTION 1350     The undersigned, Donald B. Murray, the Chief Executive Officer of Resources Connection, Inc.,and Nathan W. Franke, Chief Financial Officer of Resources Connection, Inc. (the “Company”), pursuantto 18 U.S.C. §1350, hereby certify that, to the best of their knowledge:     (i) the Report on Form 10-Q of the Company for the quarter ended November 30, 2007 (the“Report”) fully complies with the requirements of Section 13(a) or 15(d), as applicable, of theSecurities Exchange Act of 1934, as amended; and     (ii) the information contained in the Report fairly presents, in all material respects, thefinancial condition and results of operations of the Company.Dated: January 3, 2008              /s/ Donald B. Murray   Donald B. Murray   President and Chief Executive Officer
Exhibit 32.2

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

The undersigned, the Chief Financial Officer of Gladstone Capital Corporation (the Company), hereby certifies on the date hereof, pursuant to 18 U.S.C. §1350(a), as adopted pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report on Form 10-Q for the quarter ended March 31, 2012 (Form 10-Q), filed concurrently herewith by the Company, fully complies with the requirements of
Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934, as amended, and that the information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the
Company.

Dated: May 1, 2012



|                                     
|-------------------------------------
|/s/ David Watson                     
|David Watson                         
|Chief Financial Officer and Treasurer